New Developments

  • Pegylated Liposomal Doxorubicin (Commercial Production Available)
  • Albumin Bound Paclitaxel (Commercial Production will commence in Jan.2016)
  • Abiraterone Acetate Tablets (Commercial Production will commence in Jan.2016)
  • Fosaaprepitant Injections (Commercial Production will commence in Jan.2016)
  • Cabazitaxel Injections (Commercial Production will commence in Mar.2016)